Latest news

We are living through a very challenging time. The Coronavirus spread is causing changes in everyday life and we are constantly monitoring the situation here at Adalvo

Alvogen today announced that it has submitted generic dossier applications for Pazopanib tablets.

Alvotech Hf and DKSH, a leading healthcare provider across 36 emerging countries in South-East Asia, today announced that Alvotech Hf and DKSH have entered into an exclusive license partnership for...

This February the Adalvo team got together in Zurich, Switzerland for a Kick Off meeting.

Adalvo is delighted to partner with JSC Olainfarm to launch a new product within the urology segment which is targeted to be the 1st to market opportunity in 17 countries....

At Adalvo, we are dedicated to advancing cardiovascular health through our portfolio of differentiated treatments. Our cardiovascular range addresses a wide array of conditions, providing high-quality solutions that improve patient...

At Adalvo, we are committed to advancing the treatment of central nervous system (CNS) disorders through the development and commercialization of differentiated and high-quality pharmaceutical products. Our CNS/Neurology portfolio addresses...

At Adalvo, we are dedicated to providing advanced and effective solutions for managing pain. Our pain portfolio includes a range of high-quality, differentiated products designed to address various pain conditions...

At Adalvo, we are committed to advancing the treatment options available for patients suffering from rheumatological conditions. Our robust portfolio addresses a wide range of autoimmune and inflammatory diseases, providing...

Adalvo's Urology Dossiers feature a range of essential products designed to address various urological conditions, including urinary incontinence, overactive bladder, and more. With a focus on quality, efficacy, and patient-centric...

Adalvo's rare disease portfolio encompasses a diverse array of treatments designed to target several rare diseases. Each dossier within our portfolio is developed to improve the quality of life and...

At Adalvo, we prioritize women's health by offering a comprehensive range of products designed to address various health needs throughout every stage of a woman's life. From reproductive health to...

At Adalvo, we are committed to advancing healthcare solutions to combat infectious diseases and enhance patient outcomes worldwide. Explore our diverse portfolio of anti-infections dossiers below.

Adalvo's Diabetes portfolio dives into an expansive array of treatments, addressing the diverse requirements of patients and healthcare practitioners. From peptide injections to small molecule oral therapies, Adalvo remains committed...

At Adalvo, we understand the critical importance of providing differentiated solutions for oncology patients. Our Oncology Portfolio encompasses a comprehensive range of products designed to address various types of cancer,...